aluates Reports

$ 0.0

Automative

Global Brucella Melitensis Vaccine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-27A12787

Global Brucella Melitensis Vaccine Market Research Report 2023

BUY CHAPTERS

Global Brucella Melitensis Vaccine Market Research Report 2025

Code: QYRE-Auto-27A12787

Report

May 2025

Pages:87

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

CZ Veterinaria

JOVAC

Dollvet

Jinyu

Antigen

Onderstepoort

VETAL Animal Health Products Inc.

MSD Animal Health

Hester Biosciences Limited

Brucella Melitensis Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Brucella Melitensis Vaccine Market

The global market for Brucella Melitensis Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Brucella Melitensis Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brucella Melitensis Vaccine.

The Brucella Melitensis Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brucella Melitensis Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brucella Melitensis Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Brucella Melitensis Vaccine Market Report

Report Metric	Details
Report Name	Brucella Melitensis Vaccine Market
CAGR	5%
Segment by Type	Live Vaccines Attenuated Vaccines
Segment by Application	Commercial Farming Enterprise Private Farming
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	CZ Veterinaria, JOVAC, Dollvet, Antigen, Jinyu, Onderstepoort, VETAL Animal Health Products Inc., MSD Animal Health, Hester Biosciences Limited
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Brucella Melitensis Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Brucella Melitensis Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Brucella Melitensis Vaccine Market report?

Ans: The main players in the Brucella Melitensis Vaccine Market are CZ Veterinaria, JOVAC, Dollvet, Antigen, Jinyu, Onderstepoort, VETAL Animal Health Products Inc., MSD Animal Health, Hester Biosciences Limited

What are the Application segmentation covered in the Brucella Melitensis Vaccine Market report?

Ans: The Applications covered in the Brucella Melitensis Vaccine Market report are Commercial Farming Enterprise, Private Farming

What are the Type segmentation covered in the Brucella Melitensis Vaccine Market report?

Ans: The Types covered in the Brucella Melitensis Vaccine Market report are Live Vaccines, Attenuated Vaccines

Recommended Reports

Vaccine Types

Bacterial Vaccines

Combination & Others

1 Brucella Melitensis Vaccine Market Overview

1.1 Product Definition

1.2 Brucella Melitensis Vaccine by Type

1.2.1 Global Brucella Melitensis Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Live Vaccines

1.2.3 Attenuated Vaccines

1.3 Brucella Melitensis Vaccine by Application

1.3.1 Global Brucella Melitensis Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Commercial Farming Enterprise

1.3.3 Private Farming

1.4 Global Brucella Melitensis Vaccine Market Size Estimates and Forecasts

1.4.1 Global Brucella Melitensis Vaccine Revenue 2020-2031

1.4.2 Global Brucella Melitensis Vaccine Sales 2020-2031

1.4.3 Global Brucella Melitensis Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Brucella Melitensis Vaccine Market Competition by Manufacturers

2.1 Global Brucella Melitensis Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Brucella Melitensis Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Brucella Melitensis Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Brucella Melitensis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Brucella Melitensis Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Brucella Melitensis Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Brucella Melitensis Vaccine, Date of Enter into This Industry

2.8 Global Brucella Melitensis Vaccine Market Competitive Situation and Trends

2.8.1 Global Brucella Melitensis Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Brucella Melitensis Vaccine Players Market Share by Revenue

2.8.3 Global Brucella Melitensis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Brucella Melitensis Vaccine Market Scenario by Region

3.1 Global Brucella Melitensis Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Brucella Melitensis Vaccine Sales by Region: 2020-2031

3.2.1 Global Brucella Melitensis Vaccine Sales by Region: 2020-2025

3.2.2 Global Brucella Melitensis Vaccine Sales by Region: 2026-2031

3.3 Global Brucella Melitensis Vaccine Revenue by Region: 2020-2031

3.3.1 Global Brucella Melitensis Vaccine Revenue by Region: 2020-2025

3.3.2 Global Brucella Melitensis Vaccine Revenue by Region: 2026-2031

3.4 North America Brucella Melitensis Vaccine Market Facts & Figures by Country

3.4.1 North America Brucella Melitensis Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Brucella Melitensis Vaccine Sales by Country (2020-2031)

3.4.3 North America Brucella Melitensis Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Brucella Melitensis Vaccine Market Facts & Figures by Country

3.5.1 Europe Brucella Melitensis Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Brucella Melitensis Vaccine Sales by Country (2020-2031)

3.5.3 Europe Brucella Melitensis Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Brucella Melitensis Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Brucella Melitensis Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Brucella Melitensis Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Brucella Melitensis Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Brucella Melitensis Vaccine Market Facts & Figures by Country

3.7.1 Latin America Brucella Melitensis Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Brucella Melitensis Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Brucella Melitensis Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Brucella Melitensis Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Brucella Melitensis Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Brucella Melitensis Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Brucella Melitensis Vaccine Sales by Type (2020-2031)

4.1.1 Global Brucella Melitensis Vaccine Sales by Type (2020-2025)

4.1.2 Global Brucella Melitensis Vaccine Sales by Type (2026-2031)

4.1.3 Global Brucella Melitensis Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Brucella Melitensis Vaccine Revenue by Type (2020-2031)

4.2.1 Global Brucella Melitensis Vaccine Revenue by Type (2020-2025)

4.2.2 Global Brucella Melitensis Vaccine Revenue by Type (2026-2031)

4.2.3 Global Brucella Melitensis Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Brucella Melitensis Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Brucella Melitensis Vaccine Sales by Application (2020-2031)

5.1.1 Global Brucella Melitensis Vaccine Sales by Application (2020-2025)

5.1.2 Global Brucella Melitensis Vaccine Sales by Application (2026-2031)

5.1.3 Global Brucella Melitensis Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Brucella Melitensis Vaccine Revenue by Application (2020-2031)

5.2.1 Global Brucella Melitensis Vaccine Revenue by Application (2020-2025)

5.2.2 Global Brucella Melitensis Vaccine Revenue by Application (2026-2031)

5.2.3 Global Brucella Melitensis Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Brucella Melitensis Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 CZ Veterinaria

6.1.1 CZ Veterinaria Company Information

6.1.2 CZ Veterinaria Description and Business Overview

6.1.3 CZ Veterinaria Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 CZ Veterinaria Brucella Melitensis Vaccine Product Portfolio

6.1.5 CZ Veterinaria Recent Developments/Updates

6.2 JOVAC

6.2.1 JOVAC Company Information

6.2.2 JOVAC Description and Business Overview

6.2.3 JOVAC Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 JOVAC Brucella Melitensis Vaccine Product Portfolio

6.2.5 JOVAC Recent Developments/Updates

6.3 Dollvet

6.3.1 Dollvet Company Information

6.3.2 Dollvet Description and Business Overview

6.3.3 Dollvet Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Dollvet Brucella Melitensis Vaccine Product Portfolio

6.3.5 Dollvet Recent Developments/Updates

6.4 Antigen

6.4.1 Antigen Company Information

6.4.2 Antigen Description and Business Overview

6.4.3 Antigen Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Antigen Brucella Melitensis Vaccine Product Portfolio

6.4.5 Antigen Recent Developments/Updates

6.5 Jinyu

6.5.1 Jinyu Company Information

6.5.2 Jinyu Description and Business Overview

6.5.3 Jinyu Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Jinyu Brucella Melitensis Vaccine Product Portfolio

6.5.5 Jinyu Recent Developments/Updates

6.6 Onderstepoort

6.6.1 Onderstepoort Company Information

6.6.2 Onderstepoort Description and Business Overview

6.6.3 Onderstepoort Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Onderstepoort Brucella Melitensis Vaccine Product Portfolio

6.6.5 Onderstepoort Recent Developments/Updates

6.7 VETAL Animal Health Products Inc.

6.7.1 VETAL Animal Health Products Inc. Company Information

6.7.2 VETAL Animal Health Products Inc. Description and Business Overview

6.7.3 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product Portfolio

6.7.5 VETAL Animal Health Products Inc. Recent Developments/Updates

6.8 MSD Animal Health

6.8.1 MSD Animal Health Company Information

6.8.2 MSD Animal Health Description and Business Overview

6.8.3 MSD Animal Health Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 MSD Animal Health Brucella Melitensis Vaccine Product Portfolio

6.8.5 MSD Animal Health Recent Developments/Updates

6.9 Hester Biosciences Limited

6.9.1 Hester Biosciences Limited Company Information

6.9.2 Hester Biosciences Limited Description and Business Overview

6.9.3 Hester Biosciences Limited Brucella Melitensis Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Hester Biosciences Limited Brucella Melitensis Vaccine Product Portfolio

6.9.5 Hester Biosciences Limited Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Brucella Melitensis Vaccine Industry Chain Analysis

7.2 Brucella Melitensis Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Brucella Melitensis Vaccine Production Mode & Process Analysis

7.4 Brucella Melitensis Vaccine Sales and Marketing

7.4.1 Brucella Melitensis Vaccine Sales Channels

7.4.2 Brucella Melitensis Vaccine Distributors

7.5 Brucella Melitensis Vaccine Customer Analysis

8 Brucella Melitensis Vaccine Market Dynamics

8.1 Brucella Melitensis Vaccine Industry Trends

8.2 Brucella Melitensis Vaccine Market Drivers

8.3 Brucella Melitensis Vaccine Market Challenges

8.4 Brucella Melitensis Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

CZ Veterinaria

JOVAC

Dollvet

Jinyu

Antigen

Onderstepoort

VETAL Animal Health Products Inc.

MSD Animal Health

Hester Biosciences Limited

List of Tables

Table 1. Global Brucella Melitensis Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Brucella Melitensis Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Brucella Melitensis Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Brucella Melitensis Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Brucella Melitensis Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Brucella Melitensis Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Brucella Melitensis Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Brucella Melitensis Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Brucella Melitensis Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Brucella Melitensis Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Brucella Melitensis Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Brucella Melitensis Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Brucella Melitensis Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brucella Melitensis Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Brucella Melitensis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Brucella Melitensis Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global Brucella Melitensis Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Brucella Melitensis Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global Brucella Melitensis Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Brucella Melitensis Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Brucella Melitensis Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Brucella Melitensis Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Brucella Melitensis Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Brucella Melitensis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Brucella Melitensis Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America Brucella Melitensis Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America Brucella Melitensis Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Brucella Melitensis Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Brucella Melitensis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Brucella Melitensis Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe Brucella Melitensis Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe Brucella Melitensis Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Brucella Melitensis Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Brucella Melitensis Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Brucella Melitensis Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Brucella Melitensis Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Brucella Melitensis Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Brucella Melitensis Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Brucella Melitensis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Brucella Melitensis Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Brucella Melitensis Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Brucella Melitensis Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Brucella Melitensis Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Brucella Melitensis Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Brucella Melitensis Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Brucella Melitensis Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Brucella Melitensis Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Brucella Melitensis Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global Brucella Melitensis Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global Brucella Melitensis Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Brucella Melitensis Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Brucella Melitensis Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Brucella Melitensis Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Brucella Melitensis Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Brucella Melitensis Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Brucella Melitensis Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global Brucella Melitensis Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global Brucella Melitensis Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global Brucella Melitensis Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global Brucella Melitensis Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Brucella Melitensis Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Brucella Melitensis Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Brucella Melitensis Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Brucella Melitensis Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Brucella Melitensis Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Brucella Melitensis Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global Brucella Melitensis Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. CZ Veterinaria Company Information

Table 71. CZ Veterinaria Description and Business Overview

Table 72. CZ Veterinaria Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. CZ Veterinaria Brucella Melitensis Vaccine Product

Table 74. CZ Veterinaria Recent Developments/Updates

Table 75. JOVAC Company Information

Table 76. JOVAC Description and Business Overview

Table 77. JOVAC Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. JOVAC Brucella Melitensis Vaccine Product

Table 79. JOVAC Recent Developments/Updates

Table 80. Dollvet Company Information

Table 81. Dollvet Description and Business Overview

Table 82. Dollvet Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Dollvet Brucella Melitensis Vaccine Product

Table 84. Dollvet Recent Developments/Updates

Table 85. Antigen Company Information

Table 86. Antigen Description and Business Overview

Table 87. Antigen Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Antigen Brucella Melitensis Vaccine Product

Table 89. Antigen Recent Developments/Updates

Table 90. Jinyu Company Information

Table 91. Jinyu Description and Business Overview

Table 92. Jinyu Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Jinyu Brucella Melitensis Vaccine Product

Table 94. Jinyu Recent Developments/Updates

Table 95. Onderstepoort Company Information

Table 96. Onderstepoort Description and Business Overview

Table 97. Onderstepoort Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Onderstepoort Brucella Melitensis Vaccine Product

Table 99. Onderstepoort Recent Developments/Updates

Table 100. VETAL Animal Health Products Inc. Company Information

Table 101. VETAL Animal Health Products Inc. Description and Business Overview

Table 102. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. VETAL Animal Health Products Inc. Brucella Melitensis Vaccine Product

Table 104. VETAL Animal Health Products Inc. Recent Developments/Updates

Table 105. MSD Animal Health Company Information

Table 106. MSD Animal Health Description and Business Overview

Table 107. MSD Animal Health Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. MSD Animal Health Brucella Melitensis Vaccine Product

Table 109. MSD Animal Health Recent Developments/Updates

Table 110. Hester Biosciences Limited Company Information

Table 111. Hester Biosciences Limited Description and Business Overview

Table 112. Hester Biosciences Limited Brucella Melitensis Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Hester Biosciences Limited Brucella Melitensis Vaccine Product

Table 114. Hester Biosciences Limited Recent Developments/Updates

Table 115. Key Raw Materials Lists

Table 116. Raw Materials Key Suppliers Lists

Table 117. Brucella Melitensis Vaccine Distributors List

Table 118. Brucella Melitensis Vaccine Customers List

Table 119. Brucella Melitensis Vaccine Market Trends

Table 120. Brucella Melitensis Vaccine Market Drivers

Table 121. Brucella Melitensis Vaccine Market Challenges

Table 122. Brucella Melitensis Vaccine Market Restraints

Table 123. Research Programs/Design for This Report

Table 124. Key Data Information from Secondary Sources

Table 125. Key Data Information from Primary Sources

Table 126. Authors List of This Report

List of Figures

Figure 1. Product Picture of Brucella Melitensis Vaccine

Figure 2. Global Brucella Melitensis Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Brucella Melitensis Vaccine Market Share by Type: 2024 & 2031

Figure 4. Live Vaccines Product Picture

Figure 5. Attenuated Vaccines Product Picture

Figure 6. Global Brucella Melitensis Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Brucella Melitensis Vaccine Market Share by Application: 2024 & 2031

Figure 8. Commercial Farming Enterprise

Figure 9. Private Farming

Figure 10. Global Brucella Melitensis Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Brucella Melitensis Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Brucella Melitensis Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global Brucella Melitensis Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. Brucella Melitensis Vaccine Report Years Considered

Figure 15. Brucella Melitensis Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Brucella Melitensis Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Brucella Melitensis Vaccine Players: Market Share by Revenue in Brucella Melitensis Vaccine in 2024

Figure 18. Brucella Melitensis Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Brucella Melitensis Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Brucella Melitensis Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Brucella Melitensis Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Brucella Melitensis Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Brucella Melitensis Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Brucella Melitensis Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Brucella Melitensis Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America Brucella Melitensis Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America Brucella Melitensis Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa Brucella Melitensis Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa Brucella Melitensis Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE Brucella Melitensis Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of Brucella Melitensis Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of Brucella Melitensis Vaccine by Type (2020-2031)

Figure 52. Global Brucella Melitensis Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of Brucella Melitensis Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of Brucella Melitensis Vaccine by Application (2020-2031)

Figure 55. Global Brucella Melitensis Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. Brucella Melitensis Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Tuberculosis Vaccine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Prostate Cancer Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Zika Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Preventable Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Bordetella Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Plant based Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bordetella Vaccine for Dogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles and Rubella Vaccines Market Research Report 2025

Measles Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Measles and Rubella MR Vaccine Market Research Report 2025

Vaccine Combinations Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Clostridium Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Bacterial Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bacille Calmette Guérin Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Influenza A Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Oral Rabies Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Viral Vaccines Market Research Report 2025

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions